Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
12-hour versus 24-hour oxycodone controlled-release dose titration for cancer pain
ChiCTR1800014268Phase 4Recruiting
- Sponsor
- Zhejiang Cancer Hospital
- Start
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of oxycodone in cancer pain (2 arms), sponsored by Zhejiang Cancer Hospital. Primary endpoints: Proportion of patients with pain remission at 24 hours after titration and Proportion of patients with pain remission at 48 and 72 hours after titration. Started Jan 2018; status: recruiting.
02
Drugs
oxycodone
03
Conditions
cancer pain
Beyond the preview
Go deeper on ChiCTR1800014268.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800014268.